These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 17360712

  • 21. A study of tropomyosin's role in cardiac function and disease using thin-filament reconstituted myocardium.
    Bai F, Wang L, Kawai M.
    J Muscle Res Cell Motil; 2013 Aug; 34(3-4):295-310. PubMed ID: 23700264
    [Abstract] [Full Text] [Related]

  • 22. Effects of cardiomyopathic mutations on the biochemical and biophysical properties of the human alpha-tropomyosin.
    Hilario E, da Silva SL, Ramos CH, Bertolini MC.
    Eur J Biochem; 2004 Oct; 271(20):4132-40. PubMed ID: 15479242
    [Abstract] [Full Text] [Related]

  • 23. Structural and Functional Effects of Cardiomyopathy-Causing Mutations in the Troponin T-Binding Region of Cardiac Tropomyosin.
    Matyushenko AM, Shchepkin DV, Kopylova GV, Popruga KE, Artemova NV, Pivovarova AV, Bershitsky SY, Levitsky DI.
    Biochemistry; 2017 Jan 10; 56(1):250-259. PubMed ID: 27983818
    [Abstract] [Full Text] [Related]

  • 24. A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding.
    van de Meerakker JB, Christiaans I, Barnett P, Lekanne Deprez RH, Ilgun A, Mook OR, Mannens MM, Lam J, Wilde AA, Moorman AF, Postma AV.
    Biochim Biophys Acta; 2013 Apr 10; 1833(4):833-9. PubMed ID: 23147248
    [Abstract] [Full Text] [Related]

  • 25. Dilated cardiomyopathy mutations in alpha-tropomyosin inhibit its movement during the ATPase cycle.
    Borovikov YS, Karpicheva OE, Chudakova GA, Robinson P, Redwood CS.
    Biochem Biophys Res Commun; 2009 Apr 10; 381(3):403-6. PubMed ID: 19222994
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effect of the dilated cardiomyopathy-causing Glu40Lys TPM1 mutation on actin-myosin interactions during the ATPase cycle.
    Borovikov YS, Avrova SV, Karpicheva OE, Robinson P, Redwood CS.
    Biochem Biophys Res Commun; 2011 Aug 05; 411(3):496-500. PubMed ID: 21741356
    [Abstract] [Full Text] [Related]

  • 28. Functional analysis of a unique troponin c mutation, GLY159ASP, that causes familial dilated cardiomyopathy, studied in explanted heart muscle.
    Dyer EC, Jacques AM, Hoskins AC, Ward DG, Gallon CE, Messer AE, Kaski JP, Burch M, Kentish JC, Marston SB.
    Circ Heart Fail; 2009 Sep 05; 2(5):456-64. PubMed ID: 19808376
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype.
    Mirza M, Marston S, Willott R, Ashley C, Mogensen J, McKenna W, Robinson P, Redwood C, Watkins H.
    J Biol Chem; 2005 Aug 05; 280(31):28498-506. PubMed ID: 15923195
    [Abstract] [Full Text] [Related]

  • 31. The C terminus of cardiac troponin I stabilizes the Ca2+-activated state of tropomyosin on actin filaments.
    Galińska A, Hatch V, Craig R, Murphy AM, Van Eyk JE, Wang CL, Lehman W, Foster DB.
    Circ Res; 2010 Mar 05; 106(4):705-11. PubMed ID: 20035081
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. HCM and DCM cardiomyopathy-linked α-tropomyosin mutations influence off-state stability and crossbridge interaction on thin filaments.
    Farman GP, Rynkiewicz MJ, Orzechowski M, Lehman W, Moore JR.
    Arch Biochem Biophys; 2018 Jun 01; 647():84-92. PubMed ID: 29626422
    [Abstract] [Full Text] [Related]

  • 34. Troponin C Mutations Partially Stabilize the Active State of Regulated Actin and Fully Stabilize the Active State When Paired with Δ14 TnT.
    Baxley T, Johnson D, Pinto JR, Chalovich JM.
    Biochemistry; 2017 Jun 13; 56(23):2928-2937. PubMed ID: 28530094
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Molecular mechanisms and structural features of cardiomyopathy-causing troponin T mutants in the tropomyosin overlap region.
    Gangadharan B, Sunitha MS, Mukherjee S, Chowdhury RR, Haque F, Sekar N, Sowdhamini R, Spudich JA, Mercer JA.
    Proc Natl Acad Sci U S A; 2017 Oct 17; 114(42):11115-11120. PubMed ID: 28973951
    [Abstract] [Full Text] [Related]

  • 37. Structural basis for tropomyosin overlap in thin (actin) filaments and the generation of a molecular swivel by troponin-T.
    Murakami K, Stewart M, Nozawa K, Tomii K, Kudou N, Igarashi N, Shirakihara Y, Wakatsuki S, Yasunaga T, Wakabayashi T.
    Proc Natl Acad Sci U S A; 2008 May 20; 105(20):7200-5. PubMed ID: 18483193
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function.
    Golitsina N, An Y, Greenfield NJ, Thierfelder L, Iizuka K, Seidman JG, Seidman CE, Lehrer SS, Hitchcock-DeGregori SE.
    Biochemistry; 1997 Apr 15; 36(15):4637-42. PubMed ID: 9109674
    [Abstract] [Full Text] [Related]

  • 40. Alpha-tropomyosin mutations in inherited cardiomyopathies.
    Redwood C, Robinson P.
    J Muscle Res Cell Motil; 2013 Aug 15; 34(3-4):285-94. PubMed ID: 24005378
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.